VAALCO Energy, Inc. (EGY) At $0.75 Forms Bottom; Invuity, Inc. (IVTY) Had 4 Bullish Analysts

Among 4 analysts covering Invuity Inc (NASDAQ:IVTY), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Invuity Inc had 7 analyst reports since August 29, 2016 according to SRatingsIntel. Lake Street initiated it with “Buy” rating and $18 target in Monday, September 19 report. Craig Hallum initiated Invuity, Inc. (NASDAQ:IVTY) rating on Monday, August 29. Craig Hallum has “Buy” rating and $25 target. Piper Jaffray maintained the stock with “Buy” rating in Tuesday, July 25 report. Northland Capital maintained Invuity, Inc. (NASDAQ:IVTY) rating on Tuesday, June 13. Northland Capital has “Buy” rating and $1300 target. The stock of Invuity, Inc. (NASDAQ:IVTY) has “Buy” rating given on Wednesday, July 26 by Northland Capital. See Invuity, Inc. (NASDAQ:IVTY) latest ratings:

26/07/2017 Broker: Northland Capital Rating: Buy New Target: $13.0000 Maintain
25/07/2017 Broker: Piper Jaffray Rating: Buy New Target: $10.0000 Maintain

VAALCO Energy, Inc. (EGY) formed multiple bottom with $0.68 target or 9.00% below today’s $0.75 share price. VAALCO Energy, Inc. (EGY) has $44.11 million valuation. The stock decreased 3.85% or $0.03 during the last trading session, reaching $0.75. About 121,250 shares traded. VAALCO Energy, Inc. (NYSE:EGY) has risen 3.67% since January 6, 2017 and is uptrending. It has underperformed by 13.03% the S&P500.

Invuity, Inc., a medical technology company, develops various surgical devices to address various surgical procedures in the United States. The company has market cap of $103.69 million. The firm integrates its intelligent photonics technology platform into its single-use and reusable advanced surgical devices to address various critical intracavity illumination and visualization challenges. It currently has negative earnings. It offers various illuminated surgical devices, including Eikon LT Illuminated and Eikon illuminated retractor systems for breast oncology/oncoplastic/general/orthopedics surgeries; Saber Yankauer, a handheld illuminator for orthopedic/spine/cardiothoracic/breast/general surgeries; and Saber Frazier, a handheld illuminator for spine/orthopedic/neurosurgery surgeries.

It closed at $6.05 lastly. It is up 50.92% since January 6, 2017 and is uptrending. It has outperformed by 34.22% the S&P500.

Investors sentiment decreased to 0.58 in Q3 2017. Its down 0.85, from 1.43 in 2017Q2. It worsened, as 8 investors sold VAALCO Energy, Inc. shares while 16 reduced holdings. 5 funds opened positions while 9 raised stakes. 18.44 million shares or 4.68% less from 19.35 million shares in 2017Q2 were reported. Advisory Services Net Ltd Liability invested in 510 shares or 0% of the stock. Ancora Advisors Limited Liability Corp reported 242,276 shares. Moreover, Acg Wealth has 0.01% invested in VAALCO Energy, Inc. (NYSE:EGY). Moreover, Wilen Corporation has 0.61% invested in VAALCO Energy, Inc. (NYSE:EGY). Bank Of Ny Mellon has invested 0% in VAALCO Energy, Inc. (NYSE:EGY). Citigroup invested in 700 shares or 0% of the stock. Blackrock reported 1.30M shares. Bank & Trust Of America De accumulated 500 shares. Nine Chapters Cap Limited Liability owns 21,800 shares for 0.04% of their portfolio. Tieton Mngmt Ltd Co reported 2.32M shares. Iowa-based Cambridge Investment Research Advsrs has invested 0% in VAALCO Energy, Inc. (NYSE:EGY). Susquehanna Intll Gp Llp, a Pennsylvania-based fund reported 184,742 shares. 1.87M are held by Vanguard Grp. Geode Cap Mgmt Ltd Liability Com has 0% invested in VAALCO Energy, Inc. (NYSE:EGY). Bridgeway Capital Mgmt has 0% invested in VAALCO Energy, Inc. (NYSE:EGY).